MICB Antibodies

Santa Cruz Biotechnology features a diverse variety of MICB monoclonal antibodies for multiple research applications. MICB monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MICB, or MHC class I polypeptide-related sequence B, plays a crucial role in the immune response by presenting antigens to cytotoxic T cells, enabling recognition and elimination of infected or malignant cells. MICB expression significantly impacts viral infections and tumor immunology, making it a key target for therapeutic interventions and diagnostic applications. Researchers can utilize MICB monoclonal antibodies to explore immune system responses in various disease states. MICB monoclonal antibodies enable detailed analysis of cellular interactions and immune system regulation. Understanding MICB function contributes to developing new therapeutic strategies for cancer and infectious diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of immune system mechanisms and potential therapeutic applications.